FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2486144414> ?p ?o ?g. }

• W2486144414 endingPage "58314" @default.
• W2486144414 startingPage "58302" @default.
• W2486144414 abstract "// Hao Hu 1, * , Xi Kun Han 2 , Xiao Ran Long 3, * , Jia Fan 4 , Zhi Ping Yan 1 , Jian Hua Wang 1 , Rong Liu 1 1 Department of Interventional Radiology, Zhongshan Hospital, Shanghai Medical College, Fudan University, Shanghai, China 2 State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center of Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China 3 Sun Yat-sen University Cancer Center, Guangzhou, China 4 Liver Cancer Institute, Zhongshan Hospital, Shanghai Medical College, Fudan University, Shanghai, China * These authors have contributed equally to this work Correspondence to: Rong Liu, email: liu.rong@zs-hospital.sh.cn Hao Hu, email: huhaozsyy@126.com Keywords: nomogram, adjuvant transarterial chemoembolization, hepatocellular carcinoma Received: May 16, 2016     Accepted: July 01, 2016     Published: August 05, 2016 ABSTRACT Objective: This study sought to establish an effective and reliable prognostic nomogram to guide the decision for post-surgical adjuvant transarterial chemoembolization (PA-TACE) in patients with hepatitis B virus-related (HBV) hepatocellular carcinoma (HCC). Results: The 1, 3, 5-year overall survival rates were, respectively, 87.7%, 52.1% and 28.3% in the patients from the derivation set and 91.7%, 57.1% and 34.1% in those from the validation set. Five risk factors (HBV-DNA level, platelet count, vascular invasion, change of Child-Pugh score, and tumor diameter) in the multivariate analysis were significantly associated with prognosis. The statistical nomogram incorporated these five factors achieved good calibration and discriminatory abilities with c-index of 0.75 (95% CI 0.67 to 0.83). The findings were supported by the independent external validation set (c-index, 0.69; 95% CI 0.56 to 0.83). Patients who had a nomogram score of less than 180 was considered to have higher survival benefit from PA-TACE. Methods: The nomogram was established based on data obtained from a retrospective study on 235 consecutive patients with HBV HCC who received PA-TACE as an initial therapy from 2006 to 2010 in our center. 84 patients who were collected at another institution between 01/2008 and 12/2010 served as an external validation set. The prognostic nomogram was developed based on the data obtained before the PA-TACE procedure. Predictive accuracy and discriminative ability of the nomogram were assessed by concordance index (C-index), calibration curves, and validation set. Conclusion: The novel nomogram may achieve an optimal prognostic prediction for PA-TACE in HBV-related HCC." @default.
• W2486144414 created "2016-08-23" @default.
• W2486144414 creator A5018636031 @default.
• W2486144414 creator A5021096224 @default.
• W2486144414 creator A5029634246 @default.
• W2486144414 creator A5043418613 @default.
• W2486144414 creator A5064317688 @default.
• W2486144414 creator A5077039051 @default.
• W2486144414 creator A5077836229 @default.
• W2486144414 date "2016-08-05" @default.
• W2486144414 modified "2023-09-22" @default.
• W2486144414 title "Prognostic nomogram for post-surgical treatment with adjuvant TACE in hepatitis B virus-related hepatocellular carcinoma" @default.
• W2486144414 cites W1938358417 @default.
• W2486144414 cites W1946423182 @default.
• W2486144414 cites W1969489445 @default.
• W2486144414 cites W1975154077 @default.
• W2486144414 cites W1980938393 @default.
• W2486144414 cites W1986779528 @default.
• W2486144414 cites W2009378591 @default.
• W2486144414 cites W2017291569 @default.
• W2486144414 cites W2018332308 @default.
• W2486144414 cites W2021093893 @default.
• W2486144414 cites W2061291622 @default.
• W2486144414 cites W2068093256 @default.
• W2486144414 cites W2072554662 @default.
• W2486144414 cites W2074004139 @default.
• W2486144414 cites W2086800923 @default.
• W2486144414 cites W2125735075 @default.
• W2486144414 cites W2135640630 @default.
• W2486144414 cites W2144173184 @default.
• W2486144414 cites W2163403599 @default.
• W2486144414 cites W2167515175 @default.
• W2486144414 cites W2168776543 @default.
• W2486144414 cites W2172050766 @default.
• W2486144414 cites W2180029390 @default.
• W2486144414 cites W2276919162 @default.
• W2486144414 cites W4245784696 @default.
• W2486144414 doi "https://doi.org/10.18632/oncotarget.11078" @default.
• W2486144414 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5295432" @default.
• W2486144414 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27506942" @default.
• W2486144414 hasPublicationYear "2016" @default.
• W2486144414 type Work @default.
• W2486144414 sameAs 2486144414 @default.
• W2486144414 citedByCount "11" @default.
• W2486144414 countsByYear W24861444142017 @default.
• W2486144414 countsByYear W24861444142018 @default.
• W2486144414 countsByYear W24861444142019 @default.
• W2486144414 countsByYear W24861444142020 @default.
• W2486144414 countsByYear W24861444142021 @default.
• W2486144414 countsByYear W24861444142023 @default.
• W2486144414 crossrefType "journal-article" @default.
• W2486144414 hasAuthorship W2486144414A5018636031 @default.
• W2486144414 hasAuthorship W2486144414A5021096224 @default.
• W2486144414 hasAuthorship W2486144414A5029634246 @default.
• W2486144414 hasAuthorship W2486144414A5043418613 @default.
• W2486144414 hasAuthorship W2486144414A5064317688 @default.
• W2486144414 hasAuthorship W2486144414A5077039051 @default.
• W2486144414 hasAuthorship W2486144414A5077836229 @default.
• W2486144414 hasBestOaLocation W24861444141 @default.
• W2486144414 hasConcept C126322002 @default.
• W2486144414 hasConcept C143998085 @default.
• W2486144414 hasConcept C203014093 @default.
• W2486144414 hasConcept C2522874641 @default.
• W2486144414 hasConcept C2776231280 @default.
• W2486144414 hasConcept C2777382497 @default.
• W2486144414 hasConcept C2778019345 @default.
• W2486144414 hasConcept C2780593183 @default.
• W2486144414 hasConcept C34626388 @default.
• W2486144414 hasConcept C71924100 @default.
• W2486144414 hasConcept C90924648 @default.
• W2486144414 hasConceptScore W2486144414C126322002 @default.
• W2486144414 hasConceptScore W2486144414C143998085 @default.
• W2486144414 hasConceptScore W2486144414C203014093 @default.
• W2486144414 hasConceptScore W2486144414C2522874641 @default.
• W2486144414 hasConceptScore W2486144414C2776231280 @default.
• W2486144414 hasConceptScore W2486144414C2777382497 @default.
• W2486144414 hasConceptScore W2486144414C2778019345 @default.
• W2486144414 hasConceptScore W2486144414C2780593183 @default.
• W2486144414 hasConceptScore W2486144414C34626388 @default.
• W2486144414 hasConceptScore W2486144414C71924100 @default.
• W2486144414 hasConceptScore W2486144414C90924648 @default.
• W2486144414 hasIssue "36" @default.
• W2486144414 hasLocation W24861444141 @default.
• W2486144414 hasLocation W24861444142 @default.
• W2486144414 hasLocation W24861444143 @default.
• W2486144414 hasLocation W24861444144 @default.
• W2486144414 hasOpenAccess W2486144414 @default.
• W2486144414 hasPrimaryLocation W24861444141 @default.
• W2486144414 hasRelatedWork W1967104308 @default.
• W2486144414 hasRelatedWork W2013430378 @default.
• W2486144414 hasRelatedWork W2066194326 @default.
• W2486144414 hasRelatedWork W2095133085 @default.
• W2486144414 hasRelatedWork W2104139058 @default.
• W2486144414 hasRelatedWork W2182261892 @default.
• W2486144414 hasRelatedWork W2369572641 @default.
• W2486144414 hasRelatedWork W3007511243 @default.
• W2486144414 hasRelatedWork W3029919659 @default.
• W2486144414 hasRelatedWork W3030616408 @default.

• next